These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6186266)

  • 41. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
    Walsh LJ; Seymour GJ; Powell RN
    J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
    Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
    J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production.
    Czernielewski JM; Bagot M
    Clin Exp Immunol; 1986 Nov; 66(2):295-302. PubMed ID: 2434272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The semi-quantitative distribution of T4 and T6 surface antigens on human Langerhans cells.
    Schmitt D; Faure M; Dambuyant-Dezutter C; Thivolet J
    Br J Dermatol; 1984 Dec; 111(6):655-61. PubMed ID: 6210099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathologic study of lichenoid skin diseases: correlation between HLA-DR-positive keratinocytes or Langerhans cells and epidermotropic T cells.
    Shiohara T; Moriya N; Tanaka Y; Arai Y; Hayakawa J; Chiba M; Nagashima M
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):67-74. PubMed ID: 2450110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
    Löning T; Caselitz J; Seifert G; Weber K; Osborn M
    Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.
    Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
    J Invest Dermatol; 1984 Aug; 83(2):88-90. PubMed ID: 6206165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
    Scheynius A; Klareskog L; Forsum U
    Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavior of cutaneous Langerhans' cells and skin reactivity after gold sodium thiomalate treatment of pemphigus vulgaris.
    Blitstein-Willinger E
    Dermatologica; 1987; 174(2):68-75. PubMed ID: 3104105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
    Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
    Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mixed epidermal cell lymphocyte reaction: HLA-DR+ cells exhibit a greater immunostimulatory activity than CD1a+ cells.
    Dobmeyer TS; Dobmeyer JM; Klein SA; Schopf RE; Helm EB; Rossol R
    Adv Exp Med Biol; 1995; 378():393-6. PubMed ID: 8526102
    [No Abstract]   [Full Text] [Related]  

  • 54. Subclustering of CD1 monoclonal antibodies based on the reactivity on human Langerhans cells.
    Schmitt D; Dezutter-Dambuyant C; Brochier J; Thivolet J
    Immunol Lett; 1986 Apr; 12(4):231-5. PubMed ID: 2424832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differing cell surface distribution of human leukocyte antigen-DR molecules on epidermal Langerhans cells and eccrine duct cells.
    Imayama S; Yashima Y; Hori Y
    J Histochem Cytochem; 1992 Aug; 40(8):1191-6. PubMed ID: 1619281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrastructural documentation of HLA-DR antigen reactivity in normal human acrosyringial epithelium.
    Murphy GF; Shepard RS; Harrist TJ; Bronstein BR; Bhan AK
    J Invest Dermatol; 1983 Aug; 81(2):181-3. PubMed ID: 6348181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative phenotypic and ultrastructural characteristics of OKT6-positive cells in normal peripheral blood (adult and infant), in cord blood and in epidermis.
    Dezutter-Dambuyant C; Schmitt D; Thivolet J
    Dev Comp Immunol; 1986; 10(4):571-84. PubMed ID: 3817252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human keratinocytes express HLA-DR antigens in the tuberculin reaction.
    Scheynius A; Tjernlund U
    Scand J Immunol; 1984 Feb; 19(2):141-7. PubMed ID: 6367023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cells.
    Morhenn VB; Benike CJ; Charron DJ; Cox A; Mahrle G; Wood GS; Engleman EG
    J Invest Dermatol; 1982 Nov; 79(5):277-82. PubMed ID: 6752290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.